Transfer Learning Approaches to Improve Drug Sensitivity Prediction in Multiple Myeloma Patients
暂无分享,去创建一个
Zhi Wei | Turki Turki | Jason T. L. Wang | J. Wang | Zhi Wei | T. Turki
[1] Jorge S Reis-Filho,et al. Genetic heterogeneity and cancer drug resistance. , 2012, The Lancet. Oncology.
[2] David Grimes,et al. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] N. Cox,et al. Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines , 2014, Genome Biology.
[4] Howard A. Fine,et al. Predicting in vitro drug sensitivity using Random Forests , 2011, Bioinform..
[5] Nitesh V. Chawla,et al. SMOTE: Synthetic Minority Over-sampling Technique , 2002, J. Artif. Intell. Res..
[6] Vasile Palade,et al. microPred: effective classification of pre-miRNAs for human miRNA gene prediction , 2009, Bioinform..
[7] A. Cheng,et al. CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells , 2010, Oncogene.
[8] Thomas Lengauer,et al. ROCR: visualizing classifier performance in R , 2005, Bioinform..
[9] Himanshu S. Bhatt,et al. Submitted to Ieee Transactions on Image Processing 1 Improving Cross-resolution Face Matching Using Ensemble Based Co-transfer Learning , 2022 .
[10] Zhi Wei,et al. Learning approaches to improve prediction of drug sensitivity in breast cancer patients , 2016, EMBC.
[11] J. Grandis,et al. Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells , 2008, Molecular Cancer Therapeutics.
[12] Yoav Freund,et al. A decision-theoretic generalization of on-line learning and an application to boosting , 1997, EuroCOLT.
[13] Patricia Soteropoulos,et al. Effective classification of microRNA precursors using feature mining and AdaBoost algorithms. , 2013, Omics : a journal of integrative biology.
[14] M. Piccart,et al. Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study , 2008, British Journal of Cancer.
[15] André Elisseeff,et al. Stability and Generalization , 2002, J. Mach. Learn. Res..
[16] L. Wienkers,et al. Predicting in vivo drug interactions from in vitro drug discovery data , 2005, Nature Reviews Drug Discovery.
[17] Jason Tsong-Li Wang,et al. Inferring Gene Regulatory Networks by Combining Supervised and Unsupervised Methods , 2016, 2016 15th IEEE International Conference on Machine Learning and Applications (ICMLA).
[18] D. Roden,et al. The genetic basis of variability in drug responses , 2002, Nature Reviews Drug Discovery.
[19] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[20] Michael W. Mahoney,et al. rCUR: an R package for CUR matrix decomposition , 2012, BMC Bioinformatics.
[21] Julio Saez-Rodriguez,et al. Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties , 2012, PloS one.
[22] Hua Liu,et al. A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[23] Qiang Yang,et al. A Survey on Transfer Learning , 2010, IEEE Transactions on Knowledge and Data Engineering.
[24] Alexander Kamb,et al. Why is cancer drug discovery so difficult? , 2007, Nature Reviews Drug Discovery.
[25] O. Elemento,et al. Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies , 2014, Oncogene.
[26] Alcione de Paiva Oliveira,et al. Mirnacle: machine learning with SMOTE and random forest for improving selectivity in pre-miRNA ab initio prediction , 2016, BMC Bioinformatics.
[27] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[28] Pei Wang,et al. Integrative random forest for gene regulatory network inference , 2015, Bioinform..
[29] D. Pe’er,et al. Integration of Genomic Data Enables Selective Discovery of Breast Cancer Drivers , 2014, Cell.
[30] Chih-Ming Ho,et al. Optimization of drug combinations using Feedback System Control , 2016, Nature Protocols.
[31] Kerstin Amann,et al. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis , 2008, Nature Medicine.
[32] William Stafford Noble,et al. Machine learning applications in genetics and genomics , 2015, Nature Reviews Genetics.
[33] T. Poggio,et al. General conditions for predictivity in learning theory , 2004, Nature.
[34] Vivien Marx,et al. Cancer: A most exceptional response , 2015, Nature.
[35] Jason Tsong-Li Wang,et al. MapReduce Algorithms for Inferring Gene Regulatory Networks from Time-Series Microarray Data Using an Information-Theoretic Approach , 2017, BioMed research international.
[36] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.
[37] Sergio Contrino,et al. ArrayExpress—a public repository for microarray gene expression data at the EBI , 2004, Nucleic Acids Res..
[38] Vipin Kumar,et al. Introduction to Data Mining, (First Edition) , 2005 .
[39] Yoav Freund,et al. A decision-theoretic generalization of on-line learning and an application to boosting , 1995, EuroCOLT.
[40] Haruhiko Kimura,et al. LVQ-SMOTE – Learning Vector Quantization based Synthetic Minority Over–sampling Technique for biomedical data , 2013, BioData Mining.
[41] Laura M. Heiser,et al. A community effort to assess and improve drug sensitivity prediction algorithms , 2014, Nature Biotechnology.
[42] Jason Tsong-Li Wang,et al. A New Approach to Link Prediction in Gene Regulatory Networks , 2015, IDEAL.
[43] Vipin Kumar,et al. Introduction to Data Mining , 2022, Data Mining and Machine Learning Applications.
[44] Petros Drineas,et al. CUR matrix decompositions for improved data analysis , 2009, Proceedings of the National Academy of Sciences.
[45] K. Shen,et al. Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer , 2008 .
[46] Zhi Wei,et al. A Noise-Filtering Approach for Cancer Drug Sensitivity Prediction , 2016, ArXiv.
[47] Mandy Aujla,et al. Chemotherapy: Treating older breast cancer patients , 2009, Nature Reviews Clinical Oncology.
[48] Alexander Aliper,et al. Combinatorial high-throughput experimental and bioinformatic approach identifies molecular pathways linked with the sensitivity to anticancer target drugs , 2015, Oncotarget.
[49] Jason Tsong-Li Wang,et al. A Learning Framework to Improve Unsupervised Gene Network Inference , 2016, MLDM.
[50] Zhi Wei,et al. Top-k Parametrized Boost , 2014, MIKE.
[51] Rebecca L. Siegel Mph,et al. Cancer statistics, 2016 , 2016 .
[52] Harris Drucker,et al. Improving Regressors using Boosting Techniques , 1997, ICML.
[53] S. Muthukrishnan,et al. Relative-Error CUR Matrix Decompositions , 2007, SIAM J. Matrix Anal. Appl..
[54] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[55] V. Brusic,et al. Mathematical modeling for novel cancer drug discovery and development , 2014, Expert opinion on drug discovery.
[56] Nci Dream Community. A community effort to assess and improve drug sensitivity prediction algorithms , 2014 .